e-learning
resources
Vienna 2012
Sunday, 02.09.2012
COPD is not a pulmonary disease alone
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease
P. Boschetto, I. Campo, M. Stendardo, E. Casimirri, C. Tinelli, C. Ceconi, A. Fucili, A. Potena, L. Ballerin, L. M. Fabbri, M. Luisetti (Pavia, Modena, Italy)
Source:
Annual Congress 2012 - COPD is not a pulmonary disease alone
Session:
COPD is not a pulmonary disease alone
Session type:
Poster Discussion
Number:
213
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Boschetto, I. Campo, M. Stendardo, E. Casimirri, C. Tinelli, C. Ceconi, A. Fucili, A. Potena, L. Ballerin, L. M. Fabbri, M. Luisetti (Pavia, Modena, Italy). Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease. Eur Respir J 2012; 40: Suppl. 56, 213
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
Reduced soluble receptor for advanced glycation end-products in COPD
Source: Eur Respir J 2011; 37: 516-522
Year: 2011
Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 586s
Year: 2005
Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation?
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 459s
Year: 2004
Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Association between endothelial dysfunction and nutrient consumption in patients with chronic obstructive pulmonary disease and heart failure.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 226s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept